Scholars Central

Conference abstract

In vivo evaluation of pre-activated Ã?±-cyclodextrins as a mucoadhesive intra-vesical drug delivery system

Authors: Muhammad Ijaz, Farzana Choudry, Muhammad Khurram Waqas, Flavia Laffleur, Andreas Bernkop-Schnurch

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The study was designed to synthesize and characterize pre-activated Ã?±-cyclodextrin (Ã?±-CD) derivatives as mucus adhering excipients for intra-vesical drug delivery. Sodium periodate (NaIO4) was used to oxidize Ã?±-CD and subsequently cysteamine was covalently attached to carbonyl groups of oxidized Ã?±-CD via reductive amination to produce thiolated Ã?±-CD. L-cysteine-2mercaptonicotinic acid conjugate (Cys-MNA) was covalently attached to carbonyl groups of oxidized Ã?±-CD to produce pre-activated Ã?±-CD having enhance stability against oxidation at higher pH. Thiolated and pre-activated Ã?±-CD derivatives were quantitatively assayed for the attached thiol groups and MNA groups, respectively. Cell viability and tolerability was evaluated via Resazurin assay and via red blood cells (RBC) lysis assay, respectively. Mucoadhesive properties were evaluated on porcine bladder mucosa. Trimethoprim (TMP) was encapsulated into thiolated and pre-activated Ã?±-CD derivatives and the dissolution behavior was evaluated in vitro. Thiol groups attached to thiolated Ã?±-CD derivatives Ã?±-CD-SH780 and Ã?±-CD-SH1426 were 780Ã?±68 Ã?µmol/g and 1426Ã?±66 Ã?µmol/g, respectively. For the entirely pre-activated Ã?±-CD derivatives, Ã?±-CD-MNA3609 and Ã?±-CD-MNA4285 number of attached MNA groups were 3609Ã?±19 Ã?µmol/g and 4285Ã?±43 Ã?µmol/g, respectively. Thiolated and pre-activated derivatives of Ã?±-CD did not show adverse effects to cells determined via Resazurin and RBC lysis assays. Mucoadhesion on porcine bladder mucosa was significantly improved for thiolated and pre-activated Ã?±-CD derivatives. Thiolated Ã?±-CD-SH1426 showed 15-fold and pre-activated Ã?±-CD-MNA4285 showed 25-fold improved mucoadhesion compared to unmodified Ã?±-CD. Further, pre-activated Ã?±-CD-MNA4285 showed 2-fold enhanced dissolution of encapsulated TMP compared to free TMP over 3h. The study shows that pre-activated Ã?±-CD could be an excipient of the choice for the formulations of mucoadhesive intra-vesical drug delivery systems. PDF HTML

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Nanomedicine & Nanotechnology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Nanomedicine & Nanotechnology
  • SubjectNanotechnology
  • BylineArticles whose byline prints “Muhammad Ijaz”
  • BylineArticles whose byline prints “Farzana Choudry”
  • BylineArticles whose byline prints “Muhammad Khurram Waqas”
  • BylineArticles whose byline prints “Flavia Laffleur”
  • BylineArticles whose byline prints “Andreas Bernkop-Schnurch”